Gastrointestinal (GI) cancers account for nearly 150,000 deaths each year, in the United States alone. Encouragingly, environmental risk factors, premalignant conditions, and high-risk familial kindreds are well described for many GI cancers. In this comprehensive volume on GI Neoplasia, all luminal cancers will be discussed, along with pancreas cancer, gastrointestinal stromal tumors (GISTs), carcinoid tumors, and neuroendocrine tumors. Hepatobiliary cancers are not addressed, as these tumors could form the basis of a separate volume. Articles are organized to address several key topics for each cancer type, such as: public health burden, molecular pathways, risk and protective factors, early detection, clinical evaluation, management, and survivorship.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. Esophageal Cancer - p. 399 9. Current Perspectives on Gastric Cancer - p. 413 10. Pancreatic Cancer: A Review - p. 429 11. Small Bowel Adenocarcinoma - p. 447 12. Colorectal Cancer: Genetics is Changing Everything - p. 459 13. Knowns and Known Unknowns of Gastrointestinal Stromal Tumor Adjuvant Therapy - p. 477 14. Neuroendocrine Tumors - p. 487 15. Heritable Gastrointestinal Cancer Syndromes - p. 509 16. Molecular Detection of Gastrointestinal Neoplasia: Innovations in Early Detection and Screening - p. 529 17. The Role of the Microbiome in Gastrointestinal Cancer - p. 543 18. Index - p. 557
No hay muestra disponible
No hay ficha técnica disponible
Gastrointestinal (GI) cancers account for nearly 150,000 deaths each year, in the United States alone. Encouragingly, environmental risk factors, premalignant conditions, and high-risk familial kindreds are well described for many GI cancers. In this comprehensive volume on GI Neoplasia, all luminal cancers will be discussed, along with pancreas cancer, gastrointestinal stromal tumors (GISTs), carcinoid tumors, and neuroendocrine tumors. Hepatobiliary cancers are not addressed, as these tumors could form the basis of a separate volume. Articles are organized to address several key topics for each cancer type, such as: public health burden, molecular pathways, risk and protective factors, early detection, clinical evaluation, management, and survivorship.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. Esophageal Cancer - p. 399 9. Current Perspectives on Gastric Cancer - p. 413 10. Pancreatic Cancer: A Review - p. 429 11. Small Bowel Adenocarcinoma - p. 447 12. Colorectal Cancer: Genetics is Changing Everything - p. 459 13. Knowns and Known Unknowns of Gastrointestinal Stromal Tumor Adjuvant Therapy - p. 477 14. Neuroendocrine Tumors - p. 487 15. Heritable Gastrointestinal Cancer Syndromes - p. 509 16. Molecular Detection of Gastrointestinal Neoplasia: Innovations in Early Detection and Screening - p. 529 17. The Role of the Microbiome in Gastrointestinal Cancer - p. 543 18. Index - p. 557
No hay muestra disponible
No hay ficha técnica disponible
